Fig. 1From: Effects of dyslipidemia on E antigen seroconversion of patients with chronic hepatitis B treated by nucleoside (acid) analogsComparison of the HBeAg serological conversion rates between dyslipidemia and normolipidemic groups at different treatment times. *Comparison between dyslipidemia and normolipidemic groups P < 0.05Back to article page